Ignite Creation Date:
2025-12-24 @ 1:19 PM
Ignite Modification Date:
2026-02-03 @ 7:24 AM
Study NCT ID:
NCT02873195
Status:
COMPLETED
Last Update Posted:
2024-08-23
First Post:
2016-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer
Sponsor:
Academic and Community Cancer Research United
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-01
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-16
First Submit QC Date:
None
Study First Post Date:
2016-08-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-01-23
Results First Submit QC Date:
None
Results First Post Date:
2020-02-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-30
Last Update Post Date:
2024-08-23
Last Update Post Date Type:
ACTUAL